Korro Bio, Inc. (KRRO) Stock Forecast
KRRO analyst forecast
as of October 18, 2026- Analyst consensus
- Strong buy 4.64 / 5 from 11 analysts
- Price target
- $20.20 average of analyst targets
- Upside to target
- +137.9% from the latest close
- Next earnings
- November 11, 2026 EPS estimate $-1.14
- 52-week range
- $5.28 – $46.35
KRRO analyst ratings
11 analystsNumber of analysts at each rating.
KRRO price target
The average of analyst 12-month price targets compared with the latest close and the 52-week range.
KRRO earnings per share estimates
| Period | Average | Low | High | Year ago | Growth | Analysts |
|---|---|---|---|---|---|---|
| Current quarter (Sep '26) | −$1.26 | −$2.04 | −$0.93 | −$1.92 | +34.3% | 10 |
| Current fiscal year (2026) | −$5.23 | −$7.25 | −$4.22 | −$8.81 | +40.6% | 10 |
| Next fiscal year (2027) | −$4.42 | −$5.04 | −$3.55 | −$5.23 | +15.5% | 8 |
Consensus EPS estimates; growth compares the average estimate with the year-ago EPS.
KRRO revenue estimates
| Period | Average | Low | High | Growth | Analysts |
|---|---|---|---|---|---|
| Current quarter (Sep '26) | $187,500 | $0 | $1.5M | −82.8% | 8 |
| Current fiscal year (2026) | $375,000 | $0 | $3.0M | −94.1% | 8 |
| Next fiscal year (2027) | $587,500 | $0 | $2.7M | +56.7% | 8 |
KRRO EPS: reported and forecast
Fiscal years; "E" marks estimates, the line shows the range from the lowest to the highest estimate.
KRRO revenue: reported and forecast
KRRO EPS estimate revisions
| Period | 90 days ago | 60 days ago | 30 days ago | 7 days ago | Now | Change (90 d) | Revisions (30 d) |
|---|---|---|---|---|---|---|---|
| Current quarter (Sep '26) | −$1.27 | −$1.25 | −$1.25 | −$1.25 | −$1.26 | −0.5% | 0 up · 1 down |
| Current fiscal year (2026) | −$5.18 | −$5.18 | −$5.18 | −$5.18 | −$5.23 | +1.1% | 0 up · 1 down |
| Next fiscal year (2027) | −$5.04 | −$4.46 | −$4.46 | −$4.46 | −$4.42 | −12.3% | 4 up · 0 down |
How the consensus EPS estimate changed over the last 90 days, and how many analysts raised or lowered it in the last 30 days.
KRRO earnings surprises
Reported EPS vs the consensus estimate for the last 12 quarters; KRRO beat in 10 of 12.
What analysts expect from KRRO
11 analysts cover Korro Bio; their consensus rating is strong buy (4.64 on a 1–5 scale, where 5 is a strong buy). The average price target is $20.20, 137.9% above the latest close of $8.49. Analysts expect earnings of −$5.23 per share for 2026, +40.6% from a year earlier. For 2027 the average estimate is −$4.42 per share on revenue of $0.6 million. Korro Bio beat the EPS estimate in 10 of the last 12 quarters.
Related: KRRO income statement, KRRO key metrics, KRRO chart. See the KRRO stock overview for the latest quote and news.
KRRO forecast FAQ
What is Korro Bio's price target?
The average analyst price target for Korro Bio is $20.20, 137.9% above the latest close of $8.49.
Is Korro Bio a buy, hold or sell?
Of 11 analysts covering Korro Bio, 8 rate it a strong buy, 2 a buy, 1 a hold, 0 a sell and 0 a strong sell, a consensus of strong buy. Ratings are opinions, not a recommendation from Quotelinks.
What is Korro Bio's EPS forecast?
Analysts forecast −$5.23 per share for 2026 (range −$7.25 to −$4.22); for 2027 the estimate is −$4.42.
What is Korro Bio's revenue forecast?
The average revenue estimate for 2026 is $0.4 million, growth of −94.1%; for 2027 it is $0.6 million.
When does Korro Bio report earnings?
Korro Bio is expected to report results for the quarter ending September 30, 2026 on November 11, 2026; the EPS estimate is $-1.14.
Does Korro Bio usually beat earnings estimates?
Korro Bio reported EPS at or above the analyst estimate in 10 of the last 12 quarters.